Robotic synthesis of 6-[F]fluoro-L-dopa

Nuclear Medicine Communications

Volumn 21, Issue 9, 2000, Pages 799-802

  Chang, C W ^a   Wang, H E ^b   Lin, H M ^b   Chtsai, C S ^b   Chen, J B ^b   Liu, R S ^b  

^a National PET/Cyclotron Center   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE; FLUORINE; FLUORODOPA F 18;

ARTICLE; ISOLATION AND PURIFICATION; SYNTHESIS;

DIHYDROXYPHENYLALANINE; FLUORINE RADIOISOTOPES;

EID: 0034278034     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200009000-00003     Document Type: Article

References (11)

1. Volkow ND, Fowler JS, Gatley SJ et al. PET evaluation of the dopamine system of the human brain. J Nucl Med 1996; 37: 1242-1256.
2. Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 1976; 192: 481-483.
3. Kung HF. SPECT and PET ligands for CNS imaging. Neurotransmission 1993; 6: 1-6.
4. 18F]6-fluorodopa. Appl Radiat Isot 1986; 37: 877-882.
5. 18F]fluoro-L-dopa for human studies with PET. Appl Radiat Isot 1990; 41: 275-281.
6. 18F]fluoro-L-dopa. Appl Radiat Isot 1992; 43: 989-996.
7. 18F]6-fluorodopa with fluorine-18 acetyl hypofluorite. J Nucl Med 1986; 27: 1462-1466.
8. 18F]l-6-fluorodopa. Int J Appl Radiat Isot 1984; 25: 651-653.
9. 18F]fluoro-L-dopa. J Nucl Med 1986; 27: 417-421.
10. 18F]fluoro-L-dopa. J Nucl Med 1984; 25: 1228-1233.
11. Diksic M, Farrokhzad S. New synthesis of fluorine-18-labelled 6-fluoro-L-dopa by cleaving the carbon-silicon bond with fluorine. J Nucl Med 1985; 26: 1314-1318.